The Oncology Institute Schedules Q4 and Full-Year 2025 Earnings Call
Event summary
- The Oncology Institute (NASDAQ: TOI) will release Q4 and full-year 2025 financial results on March 12, 2026.
- Conference call scheduled for 5:00 p.m. ET on the same day, with replay available until March 19, 2026.
- TOI operates over 100 clinics and affiliate locations across five states, serving approximately 1.9 million patients.
- Company employs over 180 clinicians and offers clinical trials, transfusions, and other advanced care delivery models.
The big picture
The Oncology Institute's earnings release and conference call come at a time when value-based care models are gaining traction in oncology. The company's focus on community-based, specialized cancer care positions it uniquely in a market increasingly prioritizing cost-effective, high-quality treatment options. With over 100 clinics and a growing clinician network, TOI's performance will be closely watched as an indicator of the broader shift towards decentralized cancer care.
What we're watching
- Financial Performance
- How Q4 and full-year 2025 results reflect TOI's expansion and operational efficiency in community oncology.
- Market Dynamics
- Whether TOI can sustain growth amid increasing competition in the value-based cancer care sector.
- Operational Scale
- The pace at which TOI expands its clinic network and clinician base to maintain market leadership.
Related topics